These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17322179)

  • 1. Improving adherence in patients with alcohol dependence: a new role for pharmacists.
    Peterson AM
    Am J Health Syst Pharm; 2007 Mar; 64(5 Suppl 3):S23-9. PubMed ID: 17322179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging approaches to managing alcohol dependence.
    Swift R
    Am J Health Syst Pharm; 2007 Mar; 64(5 Suppl 3):S12-22. PubMed ID: 17322178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The state of pharmacotherapy for the treatment of alcohol dependence.
    Garbutt JC
    J Subst Abuse Treat; 2009 Jan; 36(1):S15-23; quiz S24-5. PubMed ID: 19062347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alcohol dependence and pharmacologic treatment. Introduction.
    McDonough KP
    Am J Health Syst Pharm; 2007 Mar; 64(5 Suppl 3):S3-4. PubMed ID: 17322180
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pharmacological review of alcoholic dependence treatment].
    Oural L; Paris MV; Sullivan O; Polach M; Pavlovsky F; Capece J
    Vertex; 2008; 19(77):512-21. PubMed ID: 18443665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alcohol dependence: after the withdrawal phase. Long-term abstinence: better health and psychosocial status. Psychosocial support for a chronic disorder. Some drugs are useful adjuncts to medical support.
    Prescrire Int; 2009 Oct; 18(103):222-3. PubMed ID: 19882797
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacotherapy, pharmacogenomics, and the future of alcohol dependence treatment, part 1.
    Kenna GA; McGeary JE; Swift RM
    Am J Health Syst Pharm; 2004 Nov; 61(21):2272-9. PubMed ID: 15552634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medications for treating alcohol dependence.
    Williams SH
    Am Fam Physician; 2005 Nov; 72(9):1775-80. PubMed ID: 16300039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.
    Anton RF; O'Malley SS; Ciraulo DA; Cisler RA; Couper D; Donovan DM; Gastfriend DR; Hosking JD; Johnson BA; LoCastro JS; Longabaugh R; Mason BJ; Mattson ME; Miller WR; Pettinati HM; Randall CL; Swift R; Weiss RD; Williams LD; Zweben A;
    JAMA; 2006 May; 295(17):2003-17. PubMed ID: 16670409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New therapies for alcohol problems: application to primary care.
    Fiellin DA; Reid MC; O'Connor PG
    Am J Med; 2000 Feb; 108(3):227-37. PubMed ID: 10723977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review.
    Bouza C; Angeles M; Muñoz A; Amate JM
    Addiction; 2004 Jul; 99(7):811-28. PubMed ID: 15200577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acamprosate for the treatment of alcohol dependence.
    Boothby LA; Doering PL
    Clin Ther; 2005 Jun; 27(6):695-714. PubMed ID: 16117977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New pharmacotherapies for alcohol dependence: are they being used and what do they cost?
    Doran CM; Fawcett JE; Shakeshaft AP; Shanahan MD; Mattick RP
    Med J Aust; 2003 Aug; 179(4):218. PubMed ID: 12914502
    [No Abstract]   [Full Text] [Related]  

  • 14. Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial.
    Morley KC; Teesson M; Reid SC; Sannibale C; Thomson C; Phung N; Weltman M; Bell JR; Richardson K; Haber PS
    Addiction; 2006 Oct; 101(10):1451-62. PubMed ID: 16968347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcohol dependence treatments: comprehensive healthcare costs, utilization outcomes, and pharmacotherapy persistence.
    Baser O; Chalk M; Rawson R; Gastfriend DR
    Am J Manag Care; 2011 Jun; 17 Suppl 8():S222-34. PubMed ID: 21761948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal patterns of adherence to medications and behavioral treatment and their relationship to patient characteristics and treatment response.
    Gueorguieva R; Wu R; Krystal JH; Donovan D; O'Malley SS
    Addict Behav; 2013 May; 38(5):2119-27. PubMed ID: 23435273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Meta-analysis of pharmacological therapy with acamprosate, naltrexone, and disulfiram--a systematic review].
    Petrov I; Krogh J; Nordentoft M
    Ugeskr Laeger; 2011 Nov; 173(48):3103-9. PubMed ID: 22118653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapy of alcohol dependence: a review of the clinical data.
    Mann K
    CNS Drugs; 2004; 18(8):485-504. PubMed ID: 15182219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost and cost-effectiveness of the COMBINE study in alcohol-dependent patients.
    Zarkin GA; Bray JW; Aldridge A; Mitra D; Mills MJ; Couper DJ; Cisler RA;
    Arch Gen Psychiatry; 2008 Oct; 65(10):1214-21. PubMed ID: 18838638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acamprosate.
    Mason BJ
    Recent Dev Alcohol; 2003; 16():203-15. PubMed ID: 12638639
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.